Show
Sort by
-
Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice
-
Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance
-
Therapeutic drug delivery by genetically modified Lactococcus lactis
-
Altered gut transcriptome in spondyloarthropathy
-
Genetically modified Lactococcus lactis: novel tools for drug delivery
-
Clinical potential of Lactococcus lactis mediated delivery of human Interleukin-10 and Trefoil Factors
-
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
-
- Journal Article
- A1
- open access
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease
-
Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10
-
Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis